ALNY

Q: What is the price of Alnylam Pharmaceuticals (ALNY) today?

The price of Alnylam Pharmaceuticals (ALNY) today is US$ 460,46, with a variation of 61.95% compared to the last year. The price of Alnylam Pharmaceuticals (ALNY) started the year trading around US$ 0,00 and today it is at US$ 460,46. Follow the real-time price chart, the historical price of Alnylam Pharmaceuticals (ALNY), and stock data from Ibovespa and international markets.

Q: When does Alnylam Pharmaceuticals (ALNY) pay dividends?

Alnylam Pharmaceuticals (ALNY) did not distribute dividends in the last year.

Q: Alnylam Pharmaceuticals (ALNY) is it worth it?

Currently, Alnylam Pharmaceuticals (ALNY) is priced at US$ 460,46, with a P/E of -218,34%, representing a deviation of -95,32% from its historical average P/E. In the last year, the stock showed a variation of 61.95% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 61,95%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Alnylam Pharmaceuticals (ALNY)?

Investing in stocks of Alnylam Pharmaceuticals (ALNY) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Alnylam Pharmaceuticals (ALNY) yield today?

The yield of Alnylam Pharmaceuticals (ALNY) was -1,89% in the last month, 61,95% in the last year and 213,24% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Alnylam Pharmaceuticals (ALNY) today, the total investment would be US$ 46.046,00, based on the current price of US$ 460,46.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 74.571,50In 5 years: US$ 144.234,49In 10 years: 266.831,97It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Alnylam Pharmaceuticals Inc.

Price

US$ 460,46

variation (12m)

61,95%

p/l

-218,34

p/vp

238,56

DIVIDEND YIELD

0,00%

price ALNY

BVMF

ALNY

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of ALNY

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-1,89%

3 months

46,21%

1 year

61,95%

2 years

178,58%

5 years

213,24%

10 years

479,49%

real profitability

profitability minus inflation.

1 month

-1,89%

3 months

45,67%

1 year

54,85%

2 years

154,26%

5 years

131,48%

10 years

246,95%

Indicators ALNY

check out the fundamentals of Alnylam Pharmaceuticals shares

P/E

-218,34

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

21,86

Sector: -4,23 Industry: -4,23

P/BV

238,56

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-6,00%

Sector: -63,87% Industry: -63,87%

ROE

-109,26%

Sector: -70,87% Industry: -70,87%

ROIC

-10,03%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

-10,01%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

83,19%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

-4,37%

Sector: -41,04% Industry: -41,04%

P/EBITDA

-564,67

Sector: -3,65 Industry: -3,65

P/EBIT

-403,50

Sector: -3,64 Industry: -3,64

P/ASSET

13,09

Sector: 1,41 Industry: 1,41

BVPS

1,91

Sector: 1,84 Industry: 1,84

EPS

-2,09

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,05

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

39,42%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-21,68%

Sector: - Industry: -

ALNY indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%

comparison of ALNY with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History ALNY

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc.

Average user rating I10

4.0 (2 people)

Estados Unidos

22 years

Foundation: 2003

2004

Year of debut on the stock exchange - 21 years

1.453

Employees

The Company Alnylam Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 59,78 Billions, having a net worth of $ 250,59 Milhões.

With a total of 1.453 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 2,73 Billions, which generated a loss in the amount of $ -273,80 Milhões.

As for its main indicators, the Company has a P/E ratio of -218,34, a P/BV ratio of 238,56 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ALNY.

Market value

US$ 59,78 Billions

Net worth

US$ 250,59 Milhões

US$ 250.590.000,00

Assets

US$ 4,57 Billions

US$ 4.566.020.000,00

Total Number of Shares

131,00 Milhões

131.000.000

Average Daily Trading Volume

US$ 1,22 Million

US$ 1.221.742,62

Sector

Health Care

Industry

Biotechnology

ALNY

ALNY revenue and profits

ALNY results

DRAG THE FRAME TO SEE MORE DATA

ALNY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

ALNY

Alnylam Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of ALNY

check out the fundamentals of Alnylam Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc.

Estados Unidos

22 years

2004

1.453

PROFIT X PRICE ALNY

ALNY results

ALNY cash flow

evolution of assets - ALNY

ALNY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions